AU Patent

AU2018298043A1 — Novel secnidazole soft gelatin capsule formulations and uses thereof

Assigned to Lupin Inc · Expires 2020-02-20 · 6y expired

What this patent protects

Embodiments described herein are directed to novel soft gelatin capsule formulations for intravaginal administration comprising secnidazole compounds and methods and uses of these pharmaceutical compositions in the treatment of bacterial vaginosis.

USPTO Abstract

Embodiments described herein are directed to novel soft gelatin capsule formulations for intravaginal administration comprising secnidazole compounds and methods and uses of these pharmaceutical compositions in the treatment of bacterial vaginosis.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018298043A1
Jurisdiction
AU
Classification
—
Expires
2020-02-20
Drug substance claim
No
Drug product claim
No
Assignee
Lupin Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.